Maridea Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
+105,600
New +$1.28M 0.13% 179
2025
Q3
Sell
-34,887
Closed -$618K 419
2025
Q2
$618K Sell
34,887
-186,768
-84% -$3.64M 0.16% 122
2025
Q1
$4.62M Buy
221,655
+155,228
+234% +$2.94M 1.51% 14
2024
Q4
$1.23M Buy
+66,427
New +$1.28M 0.4% 42

Other funds holding BTAL

Maridea Wealth Management's BTAL Position: Q2 2026 in Review

Maridea Wealth Management opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 105,600 shares worth $1.18M. The stake represents 0.13% of the portfolio and ranks #179 among its holdings. This is a return to the name: Maridea Wealth Management previously reported a position in BTAL as recently as Q2 2025.

Maridea Wealth Management first reported a position in BTAL in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.62M in Q1 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Maridea Wealth Management held 105,600 shares of AGF US Market Neutral Anti-Beta Fund worth $1.18M as of Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund was a new Maridea Wealth Management position in Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund made up 0.13% of Maridea Wealth Management's portfolio in Q2 2026, its #179 holding.
  • Maridea Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and has held it in 4 quarters since.
  • Maridea Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $4.62M in Q1 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Maridea Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.